EMBLEM™ S-ICD System
Subcutaneous Implantable Defibrillator

Who should be considered for the S-ICD System*
Characterization of Patient Groups for S-ICD Implantation based on the Poole and Gold editorial article:
S-ICD System is the
preferred device3
- No venous access (occluded or congenital)
- High risk of complications for TV-ICD (dialysis, pediatric immunocompromised)
- Channelopathies (LQT, Brugada, HCM)
- Previous device infections or lead failures
- H/O endocarditis
S-ICD System should be
strongly considered3
- Young patients
- Life expectancy > 10 yr
- Primary prevention with ischemic/non-ischemic heart failure
- Prosthetic valves
- Women (preferred generator placement)
- Selected secondary prevention (survivors of out of hospital VF, no evidence of MVT)
S-ICD System should be
avoided3
- Systolic HF and LBBB --> CRT
- Symptomatic bradycardia requiring pacing
- Recurrent sustained MVT for whom ATP is deemed appropriate
* Based on the article by Dr. Jeanne Poole and Dr. Michael Gold: Poole, J and Gold, M. Who Should Receive the Subcutaneous Implanted Defibrillator? The Subcutaneous Implantable Cardioverter Defibrillator Should be Considered in all ICD patients Who Do not Require Pacing. Circulation 2013; 6: 1236-1245.
Sources:
- Weiss, et al. The safety and efficacy of a totally subcutaneous implantable defibrillator. Circulation 2013.
- Burke MC et al. Pooled Analysis of the EFFORTLESS and IDE Registry. JACC 2015; online April 20th. This analysis included only S-ICD System Model 1010.
- Poole, J and Gold, M. Who Should Receive the Subcutaneous Implanted Defibrillator? The Subcutaneous Implantable Cardioverter Defibrillator Should be Considered in all ICD patients Who Do not Require Pacing. Circulation 2013; 6: 1236-1245.